Skip to main content
. 2019 Apr 4;11:2719–2727. doi: 10.2147/CMAR.S178482

Table 5.

Student’s t-test for HRQoL scores according to mIBI scores 0–1 vs 2–3.

QoL variable mIBI 0–1 mIBI 2–3 P-value
EORTC QLQ-C30
 C30 Physical functioning 80.0 (19.8) 63.6 (25.3) <0.0001
 C30 Role functioning 85.3 (25.1) 63.5 (35.3) <0.0001
 C30 Emotional functioning 71.8 (23.5) 68.9 (27.6) 0.2329
 C30 Cognitive functioning 79.1 (23.7) 74.8 (25.4) 0.0658
 C30 Social functioning 76.2 (26.2) 60.0 (32.2) <0.0001
 C30 Global QoL 58.9 (23.9) 45.3 (27.2) <0.0001
 C30 Fatigue 33.4 (27.4) 52.9 (29.1) <0.0001
 C30 Nausea/vomiting 6.1 (14.1) 16.6 (26.1) <0.0001
 C30 Pain 24.7 (28.5) 40.4 (32.8) <0.0001
 C30 Dyspnoea 24.6 (28.7) 35.6 (33.1) 0.0002
 C30 Insomnia 35.7 (34.0) 46.7 (37.1) 0.0012
 C30 Appetite loss 21.2 (30.3) 43.9 (37.4) <0.0001
 C30 Constipation 16.0 (26.7) 17.4 (26.8) 0.5753
 C30 Diarrhea 13.0 (23.2) 19.6 (29.5) 0.0094
 C30 Financial  difficulty 44.5 (36.3) 58.7 (37.0) <0.0001
 C30 Index-score 24.5 (16.5) 37.0 (20.4) <0.0001
EORTC QLQ-HCC18
 HCC18 Fatigue 27.1 (22.1) 43.4 (26.9) <0.0001
 HCC18 Body image 18.7 (20.2) 32.6 (23.3) <0.0001
 HCC18 Jaundice 21.8 (20.2) 25.4 (24.2) 0.0840
 HCC18 Nutrition 20.6 (18.0) 34.0 (22.7) <0.0001
 HCC18 Pain 19.3 (21.9) 27.8 (26.3) 0.0003
 HCC18 Fever 4.6 (12.9) 8.3 (15.9) 0.0065
 HCC18 Sex life 24.7 (31.5) 32.4 (37.1) 0.0202
 HCC18 swelling 22.0 (29.7) 44.7 (36.9) <0.0001
 HCC18 Index-score 19.8 (14.6) 31.1 (17.7) <0.0001

Notes: Data are presented as mean (SD).

Abbreviations: EORTC, European Organization for Research and Treatment of Cancer; HCC, hepatocellular carcinoma; HRQoL, health-related quality of life; mIBI, modified inflammation-based index; QoL, quality of life.